Proteostasis Therapeutics Inc.

NASDAQ: PTITechnology / Application Software / India
1.04-0.0300-2.80%Vol 388 7291Y Perf -66.45%
Jun 24th, 2019 16:00
BID1.04 ASK1.05
Open1.06 Previous Close1.07
Pre-Market1.05 After-Trading1.03
 -0.02 -1.87%  -0.01 -0.96%
Target Price
9.67 
Analyst Rating
Strong Buy 1.25
Potencial %
829.81 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-71 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/31 
Growth Ranking
★+ —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-8 
Income Ranking
 —    -
Market Cap (mil)53 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.37 
Earnings Date
14th Aug 2019

Today's Price Range

1.021.07

52wk Range

0.910010.38

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
1.96%
3 Months
-20.61%
6 Months
-70.87%
1 Year
-66.45%
3 Years
-93.19%
5 Years
-

Name / TickerPriceChg.Chg.%
PTI1.04-0.0300-2.80
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.43-0.2834.88
Q04 2018-0.46-0.3621.74
Q03 2018-0.46-0.50-8.70
Q02 2018-0.41-0.43-4.88
Q01 2018-0.51-0.3237.25
Q04 2017-0.65-0.5121.54
Q03 2017-0.63-0.5611.11
Q02 2017-0.61-0.68-11.48
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.3917.02Positive
9/2019 QR-0.4114.58Positive
12/2019 FY-1.5519.69Positive
12/2020 FY-1.730.57Positive
Next Report Date14th Aug 2019
Estimated EPS Next Report-0.39
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume388 729
Shares Outstanding (in ths.)51 099
Trades Count1 273
Dollar Volume375 245
Avg. Volume1 628 795
Avg. Weekly Volume528 788
Avg. Monthly Volume1 631 192
Avg. Quarterly Volume2 157 605
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.25
Strong Buy
1.25

Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc is a United States-based company engaged in the biotechnology industry. Its core operations comprise of discovery and development of therapeutics that treat diseases caused by an imbalance in protein biosynthesis process in the body. It has developed the Disease Relevant Translation (DRT) technology platform, a drug screening approach for identifying highly translatable therapeutics. Using this platform, it has identified a new class of small molecules and amplifiers that modulate proteins in the proteostasis network. The products under its development cycle include PTI-428, which is a lead amplifier of CFTR protein. It also focuses on developing PTI-NC-733, PTI-130, Usp14 program and unfolded protein response (UPR) program.

CEO: Meenu Chhabra

Teplephone: +1 617 225-0096

Address: 80 Guest Street, Boston 02135, MA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

65%35%

Bearish Bullish

68%32%

News